Detection of urinary podocytes by flow cytometry in idiopathic membranous nephropathy

被引:10
|
作者
Mella, Alberto [1 ]
Deambrosis, Ilaria [2 ]
Mingozzi, Silvia [1 ]
Colla, Loredana [1 ]
Burdese, Manuel [1 ]
Giaretta, Fulvia [2 ]
Bruno, Stefania [2 ,3 ]
Camussi, Giovanni [3 ]
Boaglio, Elena [1 ]
Dolla, Caterina [1 ]
Clari, Roberta [1 ]
Biancone, Luigi [1 ]
机构
[1] Univ Turin, Div Nephrol Dialysis & Transplantat, Dept Med Sci, Citta Salute & Sci Hosp, I-8810126 Corso, Italy
[2] Citta Salute & Sci Hosp, Lab Nephrol & Immunopathol, Turin, Italy
[3] Univ Turin, Dept Med Sci, Turin, Italy
关键词
DISEASE-ACTIVITY; RECEPTOR; AUTOANTIBODIES; PROGRESSION; CELLS;
D O I
10.1038/s41598-020-73335-2
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Idiopathic membranous nephropathy (iMN) is considered an immune-mediated disease where circulating autoantibodies against podocyte targets (mainly the PLA(2)R) cause the deposition of in-situ subepithelial immune-complexes. The consequent podocyte damage may cause cell detachment in urine (Podocyturia-PdoU). PdoU has been assessed in different kidney diseases, but limited data are available in iMN. In this study all patients with a diagnosis of iMN between 15/12/1999-16/07/2014 were tested for PLA(2)R antibodies (Ab anti-PLA(2)R, ELISA kit) and PdoU by flow cytometry with anti-podocalyxin antibody. A semi-quantitative PdoU score was defined according to the percentage of podocalyxin positive cells normalized to the total volume of sample and set relative to the urine creatinine measured in the supernatant. PdoU was positive in 17/27 patients (63%; 1+score in 6/27-22.2%, 2+in 4/27-14.8%, 3+in 2/27-7.4%, 4+in 5/27-18.5%). Only 2/7 patients with complete remission showed a positive PdoU (1+) while all six patients without remission have significant PdoU. PdoU+was statistically correlated with the absence of remission and Ab anti-PLA(2)R+(p<0.05) but PdoU, analysed as a continuous variable, showed a non-linear correlation with proteinuria or PLA(2)R antibody levels also in the cohort of patients with two available PdoU tests. In conclusion, PdoU could be detected in iMN and seems to be associated with commonly considered markers of disease activity (proteinuria and Ab anti-PLA(2)R) with a non-linear correlation. Despite data should be confirmed in large and prospective cohorts, according to the podocyte depletion hypothesis PdoU may represent an early marker of immunological activation with potential prognostic utility.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Urinary excretion of β2-microglobulin predicts prognosis in idiopathic membranous nephropathy
    Branten, A
    Du Buf-Vereijken, P
    Wetzels, J
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 284A - 284A
  • [42] Urinary podocytes in childhood IgA nephropathy
    Hara, M
    Yanagihara, T
    Matsuno, M
    Kihara, I
    NEPHROLOGY, 2001, 6 (04) : 179 - 184
  • [43] Association of podocyte autophagosome numbers with idiopathic membranous nephropathy and secondary membranous nephropathy
    Juan Jin
    Huifang Zhan
    Bo Lin
    Yiwen Li
    Wei Zhang
    Qiang He
    International Urology and Nephrology, 2017, 49 : 1025 - 1031
  • [44] Association of podocyte autophagosome numbers with idiopathic membranous nephropathy and secondary membranous nephropathy
    Jin, Juan
    Zhan, Huifang
    Lin, Bo
    Li, Yiwen
    Zhang, Wei
    He, Qiang
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2017, 49 (06) : 1025 - 1031
  • [45] Idiopathic Membranous Nephropathy: An Autoimmune Disease
    Makker, Sudesh P.
    Tramontano, Alfonso
    SEMINARS IN NEPHROLOGY, 2011, 31 (04) : 333 - 340
  • [46] An RCT of treatment for idiopathic membranous nephropathy
    Susan J. Allison
    Nature Reviews Nephrology, 2013, 9 (3) : 126 - 126
  • [47] IDIOPATHIC MEMBRANOUS NEPHROPATHY IN 2 SIBLINGS
    MACCARIO, M
    SEGAGNI, S
    EFFICACE, E
    PIAZZA, V
    POGGIO, F
    VILLA, G
    PICARDI, L
    BOVIO, G
    GALLI, F
    NAI, M
    BELLAZZI, R
    SALVADEO, A
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (01) : 108 - 110
  • [48] Immunosuppression and outcome in idiopathic membranous nephropathy
    Stirling, CM
    Simpson, K
    Boulton-Jones, JM
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 1998, 91 (02): : 159 - 164
  • [49] Rituximab promising for idiopathic membranous nephropathy
    Helene Myrvang
    Nature Reviews Nephrology, 2012, 8 (10) : 556 - 556
  • [50] Prediction in idiopathic membranous nephropathy.
    Marx, BE
    Becke, K
    Marx, M
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0679 - A0679